⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21140932 | 0.72 | — | — | |
| SCHEMBL13182841 | 0.70 | — | — | |
| SCHEMBL12976342 | 0.67 | — | — | |
| SCHEMBL14618960 | 0.67 | — | — | |
| SCHEMBL4294983 | 0.67 | TSHR (0.36) | — | |
| SCHEMBL21238891 | 0.65 | — | — | |
| Fluoride SCHEMBL11521122 | 0.64 | TSHR (0.33) | — | |
| SCHEMBL56628 | 0.64 | — | — | |
| SCHEMBL22236674 | 0.64 | — | — | |
| SCHEMBL1895207 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10961527-B2 | Reprogramming urokinase into an antibody-recruiting anticancer agent | YALE UNIVERSITY (US) | 2021-03-30 | — | — | US | disclosed |
| US-20130084561-A1 | BIODETECTION BY NUCLEIC ACID-TEMPLATED CHEMISTRY | COULL JAMES M (US) | 2013-04-04 | — | — | US | disclosed |
| US-20100264814-A1 | POLYMER COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2010-10-21 | — | — | US | disclosed |
| US-20100264814-A1 | POLYMER COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2010-10-21 | — | — | US | disclosed |
| EP-2223949-A1 | POLYMER COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | Idemitsu Kosan Co., Ltd. (JP) | 2010-09-01 | — | — | EP | disclosed |
| WO-2010085377-A2 | HYDROXAMIC ACID DERIVATIVES | CRYSTAL BIOPHARMACEUTICAL LLC (US) | 2010-07-29 | — | — | WO | disclosed |
| EP-1885891-A2 | BIODETECTION BY NUCLEIC ACID-TEMPLATED CHEMISTRY | Ensemble Discovery Corporation (US) | 2008-02-13 | — | — | EP | disclosed |
| US-20070154899-A1 | Biodetection by nucleic acid-templated chemistry | ENSEMBLE THERAPEUTICS CORPORATION | 2007-07-05 | — | — | US | disclosed |
| WO-2006128138-A2 | BIODETECTION BY NUCLEIC ACID-TEMPLATED CHEMISTRY | ENSEMBLE DISCOVERY CORPORTION (US) | 2006-11-30 | — | — | WO | disclosed |
| US-6103736-A | SHOWING AN INHIBITORY ACTION ON GASTRIC ACID SECRETION AND A PROTECTIVE ACTION OF GASTRIC MUCOSA; 2-(HETERO)ARYL-3-AMINOIMIDAZO-(2,1-A)ISOQUINOLINES; ANTIULCER AGENTS; | SHINNIPPON PHARMACEUTICAL INC. (JP) | 2000-08-15 | — | — | US | disclosed |
| US-6020342-A | Fused imidazo[1,2-A]pyridines | SHINNIPPON PHARMACEUTICAL, INC. (JP) | 2000-02-01 | — | — | US | disclosed |
| EP-0822194-A1 | FUSED IMIDAZO 1,2-a]PYRIDINES | Shinnippon Pharmaceutical Inc. (JP) | 1998-02-04 | — | — | EP | disclosed |